This study explores the association between receiving noninvasive ventilation at home and mortality, hospitalizations, and emergency department visits in patients with chronic obstructive pulmonary ...
Some patients with exacerbations of chronic obstructive pulmonary disease exhibit clear contraindications to noninvasive positive-pressure ventilation (NPPV); such contraindications include impending ...
High-intensity noninvasive positive pressure ventilation (NPPV) might have reduced need for endotracheal intubation for persistent hypercapnia during acute exacerbation of chronic obstructive ...
Starting noninvasive ventilation at home (NIVH) early after diagnosis was correlated with lower risk of death and reduced Medicare spending for patients with hypercapnic chronic obstructive pulmonary ...
Noninvasive ventilation is a well-known life-sparing option during acute exacerbations of chronic obstructive pulmonary disease (COPD), but its effectiveness for severe, but stable disease has been ...
Please provide your email address to receive an email when new articles are posted on . Noninvasive ventilation during exercise reduced dynamic hyperinflation and increased cycle endurance in adults ...
GLENVIEW, IL – The American College of Chest Physicians (CHEST) announces a critical milestone in its long-standing advocacy to ensure patients with COPD receive timely access to the most appropriate ...
noninvasive positive-pressure ventilation for patients with copd A novel technique involving NPPV reduced the risks of nosocomial infection, requirement for intubation, and hospital mortality in ...
No benefit of high-flow therapy (HFT) can be derived from the available study data for patients with advanced chronic obstructive pulmonary disease (COPD) or chronic type 1 respiratory failure. It ...
(RTTNews) - Royal Philips (PHG) announced the launch of Philips Ventilator BiPAP A40 EFL which comes with a new ventilation therapy feature for chronic obstructive pulmonary disease (COPD) patients to ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Receipt of an SGLT-2 inhibitor for type 2 diabetes in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback